Vibalogics announced that it initiated the first phase of its planned $150 million investment in a virotherapy facility near Boston.
The global contract development and manufacturing organization (CDMO) has a three-year investment plan which includes building a 110,000 square-foot facility, with the $150 million covering redevelopment, equipment and personnel, according to a news release.
Tell Us What You Think!